Connect Sign In
Connect with ARUP experts to learn about our comprehensive neurology testing suites and how intentional lab testing can support clinically meaningful insights across a range of neurologic conditions.
The ARUP Consult Colorectal Cancer topic highlights updated screening recommendations and guidance to help clinicians choose appropriate tests for early detection.
ARUP research highlights include cytogenetic abnormalities of pediatric B-cell acute lymphoblastic leukemia, pharmacogenomic testing, and the influence of diet on biochemical genetic testing.
New ADLM guidance helps emergency department providers choose and interpret urine drug tests, highlighting current methods, limitations, and recommended drug classes.
ARUP experts will showcase their latest research at the ASH Annual Meeting and Exposition, including updates on key clinical trials and the development of automated disease scoring.
ARUP has used novel statistical modeling approaches to establish age-specific reference ranges for pediatric patients, facilitating more accurate diagnoses of G6PD deficiency.
The FDA and the National Comprehensive Cancer Network (NCCN) urge DPYD testing before chemotherapy. ARUP offers guidance and resources to help clinicians choose and interpret genotyping tests.
ARUP experts will highlight the latest in genomic sequencing at the upcoming National Society of Genetic Counselors (NSGC) Annual Conference.
An article describing ARUP’s validation of an artificial intelligence (AI) solution to detect gastrointestinal parasites in wet mounts has been published in the Journal of Clinical Microbiology.
ARUP supports Breast Cancer Awareness Month with advanced testing, BRCA1 and BRCA2 expertise, and local blood donations that benefit patients in Utah.
